First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India

Bibliographic Details
Main Authors: Amita Gupta, David Peters, Richard E Chaisson, Tenzin Tsundue, Tenzin Namdon, Tenzin Tsewang, Sonam Topgyal, Tashi Dolma, Dekyi Lhadon, Tsering Choetso, Tenzin Woesal, Tenzin Yangkyi, Zorba Paster, Dawa Phunkyi, Tsetan Dorji Sadutshang, Kunchok Dorjee
Format: Article
Language:English
Published: BMJ Publishing Group 2022-05-01
Series:BMJ Global Health
Online Access:https://gh.bmj.com/content/7/5/e008271.full
_version_ 1811255359433605120
author Amita Gupta
David Peters
Richard E Chaisson
Tenzin Tsundue
Tenzin Namdon
Tenzin Tsewang
Sonam Topgyal
Tashi Dolma
Dekyi Lhadon
Tsering Choetso
Tenzin Woesal
Tenzin Yangkyi
Zorba Paster
Dawa Phunkyi
Tsetan Dorji Sadutshang
Kunchok Dorjee
author_facet Amita Gupta
David Peters
Richard E Chaisson
Tenzin Tsundue
Tenzin Namdon
Tenzin Tsewang
Sonam Topgyal
Tashi Dolma
Dekyi Lhadon
Tsering Choetso
Tenzin Woesal
Tenzin Yangkyi
Zorba Paster
Dawa Phunkyi
Tsetan Dorji Sadutshang
Kunchok Dorjee
author_sort Amita Gupta
collection DOAJ
first_indexed 2024-04-12T17:23:31Z
format Article
id doaj.art-736c99ed8e9b4a5e9af46341ef357dfe
institution Directory Open Access Journal
issn 2059-7908
language English
last_indexed 2024-04-12T17:23:31Z
publishDate 2022-05-01
publisher BMJ Publishing Group
record_format Article
series BMJ Global Health
spelling doaj.art-736c99ed8e9b4a5e9af46341ef357dfe2022-12-22T03:23:24ZengBMJ Publishing GroupBMJ Global Health2059-79082022-05-017510.1136/bmjgh-2021-008271First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in IndiaAmita Gupta0David Peters1Richard E Chaisson2Tenzin Tsundue3Tenzin Namdon4Tenzin Tsewang5Sonam Topgyal6Tashi Dolma7Dekyi Lhadon8Tsering Choetso9Tenzin Woesal10Tenzin Yangkyi11Zorba Paster12Dawa Phunkyi13Tsetan Dorji Sadutshang14Kunchok Dorjee15Department of Medicine, Division of Infectious Diseases, Center for Clinical Global Health Education, Johns Hopkins School of Medicine, Baltimore, Maryland, USA2Centre for Resilience, University of WestminsterCenter for TB Research, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USAPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaDepartment of Pathology, Dr. Rajendra Prasad Govt. Medical College, Tanda, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaDepartment of Family Medicine, University of Wisconsin, Oregon, Wisconsin, USAPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaDepartment of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USAhttps://gh.bmj.com/content/7/5/e008271.full
spellingShingle Amita Gupta
David Peters
Richard E Chaisson
Tenzin Tsundue
Tenzin Namdon
Tenzin Tsewang
Sonam Topgyal
Tashi Dolma
Dekyi Lhadon
Tsering Choetso
Tenzin Woesal
Tenzin Yangkyi
Zorba Paster
Dawa Phunkyi
Tsetan Dorji Sadutshang
Kunchok Dorjee
First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India
BMJ Global Health
title First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India
title_full First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India
title_fullStr First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India
title_full_unstemmed First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India
title_short First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India
title_sort first and second doses of covishield vaccine provided high level of protection against sars cov 2 infection in highly transmissible settings results from a prospective cohort of participants residing in congregate facilities in india
url https://gh.bmj.com/content/7/5/e008271.full
work_keys_str_mv AT amitagupta firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT davidpeters firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT richardechaisson firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT tenzintsundue firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT tenzinnamdon firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT tenzintsewang firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT sonamtopgyal firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT tashidolma firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT dekyilhadon firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT tseringchoetso firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT tenzinwoesal firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT tenzinyangkyi firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT zorbapaster firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT dawaphunkyi firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT tsetandorjisadutshang firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia
AT kunchokdorjee firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia